Co-Diagnostics (CODX) Metrics: History & Chart

Co-Diagnostics, Inc.(CODX)

Biotechnology · Salt Lake City, UT

$1.15+0.05 (+4.55%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Salt Lake City, UT

115 employees

co-dx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Dwight Egan

View full financials

Third-Party DCF Estimate (FMP)	$7.44
Price Gap vs Third-Party Estimate	+576.66%

7D Total Return	-0.90%
30D Total Return	-5.17%
YTD Total Return	-78.30%
1Y Total Return	-90.45%
3Y Total Return	-96.44%
5Y Total Return	-99.58%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-78.30%
2025	-77.47%
2024	-43.61%
2023	-47.22%
2022	-71.78%
2021	-3.98%
2020

CAGR TTM	-90.34%
CAGR 3Y	-67.10%
CAGR 5Y	-66.53%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	6.42
PE Ratio Avg TTM	4.85
PE Ratio Avg 3Y	5.31
Current VS TTM Avg	+32.31%
Current VS 3Y Avg	+20.94%
Current VS 5Y Avg	+20.94%

All Metrics

CODX Valuation Metrics

CODX Stock Price Metrics

CODX Dividend Metrics

CODX Growth Rate Metrics

CODX Discounted Cash Flow Metrics

CODX Returns By Period

CODX Yearly Returns

CODX Average Annual Returns By Period (CAGR)

CODX Revenue Metrics

CODX PE Ratio Metrics

CODX PS Ratio Metrics

CODX PB Ratio Metrics

CODX Price to Free Cash Flow Ratio Metrics

CODX Debt to Equity Ratio Metrics

CODX PEG Ratio Metrics

CODX FCF Yield

CODX Earnings Yield

CODX EBITDA Yield

CODX OCF Yield

CODX EV/EBIT Ratio Metrics

CODX EV/EBITDA Ratio Metrics

CODX EV/Assets Ratio Metrics

CODX EV/Sales Ratio Metrics

CODX Current Ratio Metrics

CODX Quick Ratio Metrics

CODX ROIC Metrics

CODX Return on Assets Metrics

CODX Return on Equity Metrics

CODX Net Profit Margin Metrics

CODX Gross Profit Margin Metrics

CODX Tax Rate Metrics

PS Ratio	6.57
PS Ratio Avg TTM	8.53
PS Ratio Avg 3Y	5.60
Current VS TTM Avg	-22.96%
Current VS 3Y Avg	+17.30%
Current VS 5Y Avg	+66.06%

PB Ratio	0.37
PB Ratio Avg TTM	0.25
PB Ratio Avg 3Y	0.33
Current VS TTM Avg	+45.97%
Current VS 3Y Avg	+13.45%
Current VS 5Y Avg	-12.74%

PFCF Ratio	7.45
PFCF Ratio Avg TTM	5.92
PFCF Ratio Avg 3Y	5.73
Current VS TTM Avg	+25.82%
Current VS 3Y Avg	+29.95%
Current VS 5Y Avg	+29.95%

Debt/Equity Ratio	0.14
Debt/Equity Ratio Avg TTM	0.08
Debt/Equity Ratio Avg 3Y	0.04
Current VS TTM Avg	+74.12%
Current VS 3Y Avg	+289.53%
Current VS 5Y Avg	+504.22%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	13.43%
FCF Yield Avg TTM	17.52%
FCF Yield Avg 3Y	16.31%
Current VS TTM Avg	-23.33%
Current VS 3Y Avg	-17.65%
Current VS 5Y Avg	-17.65%

Earnings Yield	15.57%
Earnings Yield Avg TTM	21.79%
Earnings Yield Avg 3Y	16.65%
Current VS TTM Avg	-28.56%
Current VS 3Y Avg	-6.51%
Current VS 5Y Avg	-6.51%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	1.23
Ev/Ebit Ratio Avg TTM	1.45
Ev/Ebit Ratio Avg 3Y	2.64
Current VS TTM Avg	-15.09%
Current VS 3Y Avg	-53.44%
Current VS 5Y Avg	-53.44%

Ev/Ebitda Ratio	1.10
Ev/Ebitda Ratio Avg TTM	1.39
Ev/Ebitda Ratio Avg 3Y	2.61
Current VS TTM Avg	-21.02%
Current VS 3Y Avg	-57.79%
Current VS 5Y Avg	-57.79%

Ev/Assets Ratio	0.17
Ev/Assets Ratio Avg TTM	0.12
Ev/Assets Ratio Avg 3Y	0.20
Current VS TTM Avg	+37.08%
Current VS 3Y Avg	-12.82%
Current VS 5Y Avg	-17.10%

Ev/Sales Ratio	4.01
Ev/Sales Ratio Avg TTM	4.29
Ev/Sales Ratio Avg 3Y	3.18
Current VS TTM Avg	-6.55%
Current VS 3Y Avg	+26.23%
Current VS 5Y Avg	+75.07%

Current Ratio	1.81
Current Ratio Avg TTM	3.18
Current Ratio Avg 3Y	6.99
Current VS TTM Avg	-42.96%
Current VS 3Y Avg	-74.06%
Current VS 5Y Avg	-83.82%

Quick Ratio	1.52
Quick Ratio Avg TTM	2.91
Quick Ratio Avg 3Y	6.64
Current VS TTM Avg	-47.74%
Current VS 3Y Avg	-77.11%
Current VS 5Y Avg	-85.76%

ROIC	(219.15%)
ROIC Avg 3Y	(64.27%)
ROIC Avg 5Y	(43.28%)
Current VS 3Y Avg	-241.00%
Current VS 5Y Avg	-406.37%
Current VS 10Y Avg	-198.41%

ROA	(283.63%)
ROA Avg TTM	(42.85%)
ROA Avg 3Y	(12.31%)
Current VS TTM Avg	-561.96%
Current VS 3Y Avg	-2204.91%
Current VS 5Y Avg	-3415.64%

ROE	(370.16%)
ROE Avg TTM	(213.63%)
ROE Avg 3Y	(59.92%)
Current VS TTM Avg	-73.28%
Current VS 3Y Avg	-517.74%
Current VS 5Y Avg	-1347.95%

Net Profit Margin	(6523.04%)
Net Profit Margin Avg TTM	(5718.81%)
Net Profit Margin Avg 3Y	(3885.78%)
Current VS TTM Avg	-14.06%
Current VS 3Y Avg	-67.87%
Current VS 5Y Avg	-165.89%

Gross Profit Margin	64.28%
Gross Pft Margin Avg TTM	14.64%
Gross Pft Margin Avg 3Y	47.84%
Current VS TTM Avg	+339.00%
Current VS 3Y Avg	+34.38%
Current VS 5Y Avg	+8.48%

Tax Rate	10.58%
Tax Rate Avg 3Y	10.90%
Tax Rate Avg 5Y	10.90%
Current VS 3Y Avg	-2.92%
Current VS 5Y Avg	-2.92%
Current VS 10Y Avg	-2.92%